RxDoctor Payments Data

Judy Miller, DO

Hospitalist · Farmington, NMNPI 1417903329

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $136 and has fallen 85.3% since, to $20 in 2021.

$211in general payments, 2019–2025

Across 12 payments — averaging $17.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$50
  • Novartis$42
  • Johnson & Johnson$30
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$20
  • Shire North American Group Inc$20
  • Paratek Pharmaceuticals, Inc.$20
  • plus $29 from 2 others

What the payments were for

  • Food & beverage$211100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$211 in reported general payments places this provider in the 75th percentile of 64 hospitalist providers in New Mexico.

See all hospitalist providers in New Mexico

Medicare billing

Part B allowed, 2024
$89,992
Medicare patients
291
Services billed
847

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate16$331
Pantoprazole Sodium15$171
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$70
Doxycycline Hyclate14$66
Amlodipine Besylate12$37
Prednisone14$25

Paid to pharmacies, not to this prescriber.

Other hospitalist in Farmington

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →